SNY:NASDAQ
Sanofi SA
39,12 US$
arrow_downward
-1,56%(-0,62) 1D
39,23 US$
arrow_upward
+0,28% (+0,11)bedtimeAfter hours
Closed: 13 ოქტ, 16:00:00 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SNY...
Open
40,12 US$
High
40,12 US$
Low
39,07 US$
Mkt. cap
95,35 მლრდ.
Avg. vol.
2,81 მლნ.
Volume
3,99 მლნ.
Dividend
6,18%
Quarterly dividend
0,60 US$
Ex-dividend date
5 მაი. 2026
P/E ratio
21,52
52-wk high
52,68 US$
52-wk low
39,07 US$
EPS
1,82 US$
Beta
0,37
Shares outstanding
2,42 მლრდ.
No. of employees
75 ათ.
Open
40,12 US$
High
40,12 US$
Low
39,07 US$
Mkt. cap
95,35 მლრდ.
Avg. vol.
2,81 მლნ.
Volume
3,99 მლნ.
Dividend
6,18%
Quarterly dividend
0,60 US$
Ex-dividend date
5 მაი. 2026
P/E ratio
21,52
52-wk high
52,68 US$
52-wk low
39,07 US$
EPS
1,82 US$
Beta
0,37
Shares outstanding
2,42 მლრდ.
No. of employees
75 ათ.
News stories
From web sources and news partners
News Corp
·
6 საათის წინ
Syndax Pharmaceuticals Stock Plunges. A Failed Trial Deals Blow to Growth Plans.
Idéal Investisseur
·
11 საათის წინ
In the upper part of the CAC 40 table, Sanofi stock rebounds by 1.5%
ad-hoc-news.de
·
12 საათის წინ
Sanofi expanded Regeneron alliance: Sanofi stock gains 1.34 percent
TipRanks
·
1 დღის წინ
Sanofi Updates Share Capital and Voting Rights Structure
Profile
Sanofi S.A. is a French multinational pharmaceutical and healthcare company headquartered in Paris. The corporation was established in 1973 and merged with Synthélabo in 1999 to form Sanofi-Synthélabo. In 2004, Sanofi-Synthélabo merged with Aventis and renamed to Sanofi-Aventis, which were each the product of several previous mergers. It changed its name back to Sanofi in May 2011. The company trades as "SAN" on Euronext Paris and "SNY" on Nasdaq in the United States, and is a component of the Euro Stoxx 50 stock market index. In 2023, the company was ranked 89th in the Forbes Global 2000.
Sanofi engages in the research and development, manufacturing, and marketing of pharmacological products, principally in the prescription market, but the firm also develops over-the-counter medications. The corporation covers seven major therapeutic areas: cardiovascular, central nervous system, diabetes, internal medicine, oncology, thrombosis, and vaccines. It is one of the world's largest producer of vaccines through its subsidiary Sanofi Pasteur. Wikipedia
About Sanofi SA
CEOბელენ გარიო | პოლ ჰადსონ
Employees74,8 ათ.
Founded1973
Headquartersპარიზი, ილ-დე-ფრანსი, საფრანგეთი
SectorPharmaceutical industry
Websitesanofi.com